FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088841888> ?p ?o ?g. }

• W2088841888 endingPage "206" @default.
• W2088841888 startingPage "201" @default.
• W2088841888 abstract "Gastrointestinal microbleeding, as assessed by the measurement of (51)chromium-labeled red blood cells, is a marker of the mucosal injury associated with the use of nonsteroidal anti-inflammatory drugs. This study tested the hypotheses that cyclooxygenase-2 specific inhibition with rofecoxib would cause less fecal blood loss than a therapeutic dose of ibuprofen and would be equivalent to placebo.In this randomized, double-blind group study, gastrointestinal blood loss was assessed by measurement of fecal (51)chromium radioactivity during a 1-week placebo baseline period and during 4 weeks of treatment with rofecoxib (25 mg or 50 mg once daily), ibuprofen (800 mg three times daily), or placebo in 67 healthy subjects. Gastrointestinal blood loss during treatment weeks 2 to 4 (versus the baseline period) was expressed as the geometric mean ratio of fecal radioactivity in weeks 2 to 4 compared with baseline.Ibuprofen caused significantly (P <0.001) greater gastrointestinal blood loss (geometric mean ratio of 5.2, 95% confidence interval [CI]: 4.2 to 6.3) than the 25-mg dose of rofecoxib (2.6, 95% CI: 2.2 to 3.1), the 50-mg dose of rofecoxib (2.6, 95% CI: 2.2 to 3.0), or placebo (2.1, 95% CI: 1.8 to 2.5). In contrast, gastrointestinal blood loss with both doses of rofecoxib were equivalent to placebo by a predetermined clinical similarity bound.In healthy subjects, treatment with rofecoxib, at 2 to 4 times the doses that are currently recommended for the treatment of patients with osteoarthritis, produced significantly less fecal blood loss than a therapeutic dose of ibuprofen and was equivalent to placebo." @default.
• W2088841888 created "2016-06-24" @default.
• W2088841888 creator A5016425613 @default.
• W2088841888 creator A5020744060 @default.
• W2088841888 creator A5026013275 @default.
• W2088841888 creator A5032780756 @default.
• W2088841888 creator A5059184078 @default.
• W2088841888 creator A5068343283 @default.
• W2088841888 creator A5074082503 @default.
• W2088841888 creator A5085871367 @default.
• W2088841888 date "2000-08-01" @default.
• W2088841888 modified "2023-10-07" @default.
• W2088841888 title "A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects" @default.
• W2088841888 cites W1536681507 @default.
• W2088841888 cites W1974274031 @default.
• W2088841888 cites W1975745945 @default.
• W2088841888 cites W1979437741 @default.
• W2088841888 cites W1981662925 @default.
• W2088841888 cites W1993725555 @default.
• W2088841888 cites W2004785777 @default.
• W2088841888 cites W2012810767 @default.
• W2088841888 cites W2016321173 @default.
• W2088841888 cites W2028912414 @default.
• W2088841888 cites W2028979689 @default.
• W2088841888 cites W2033880695 @default.
• W2088841888 cites W2035244982 @default.
• W2088841888 cites W2036115912 @default.
• W2088841888 cites W2054883739 @default.
• W2088841888 cites W2069680681 @default.
• W2088841888 cites W2083921907 @default.
• W2088841888 cites W2089107052 @default.
• W2088841888 cites W2102950559 @default.
• W2088841888 cites W2108666854 @default.
• W2088841888 cites W2115578029 @default.
• W2088841888 cites W2117227343 @default.
• W2088841888 cites W2123366546 @default.
• W2088841888 cites W2124643108 @default.
• W2088841888 cites W2239362305 @default.
• W2088841888 cites W2491373129 @default.
• W2088841888 cites W4244689754 @default.
• W2088841888 cites W2106084723 @default.
• W2088841888 doi "https://doi.org/10.1016/s0002-9343(00)00470-8" @default.
• W2088841888 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10974182" @default.
• W2088841888 hasPublicationYear "2000" @default.
• W2088841888 type Work @default.
• W2088841888 sameAs 2088841888 @default.
• W2088841888 citedByCount "80" @default.
• W2088841888 countsByYear W20888418882012 @default.
• W2088841888 countsByYear W20888418882013 @default.
• W2088841888 countsByYear W20888418882015 @default.
• W2088841888 countsByYear W20888418882017 @default.
• W2088841888 countsByYear W20888418882018 @default.
• W2088841888 countsByYear W20888418882019 @default.
• W2088841888 countsByYear W20888418882023 @default.
• W2088841888 crossrefType "journal-article" @default.
• W2088841888 hasAuthorship W2088841888A5016425613 @default.
• W2088841888 hasAuthorship W2088841888A5020744060 @default.
• W2088841888 hasAuthorship W2088841888A5026013275 @default.
• W2088841888 hasAuthorship W2088841888A5032780756 @default.
• W2088841888 hasAuthorship W2088841888A5059184078 @default.
• W2088841888 hasAuthorship W2088841888A5068343283 @default.
• W2088841888 hasAuthorship W2088841888A5074082503 @default.
• W2088841888 hasAuthorship W2088841888A5085871367 @default.
• W2088841888 hasConcept C126322002 @default.
• W2088841888 hasConcept C142724271 @default.
• W2088841888 hasConcept C168563851 @default.
• W2088841888 hasConcept C181199279 @default.
• W2088841888 hasConcept C185592680 @default.
• W2088841888 hasConcept C204787440 @default.
• W2088841888 hasConcept C27081682 @default.
• W2088841888 hasConcept C2778582115 @default.
• W2088841888 hasConcept C2779689624 @default.
• W2088841888 hasConcept C2779944601 @default.
• W2088841888 hasConcept C42219234 @default.
• W2088841888 hasConcept C55493867 @default.
• W2088841888 hasConcept C71924100 @default.
• W2088841888 hasConcept C90924648 @default.
• W2088841888 hasConcept C98274493 @default.
• W2088841888 hasConceptScore W2088841888C126322002 @default.
• W2088841888 hasConceptScore W2088841888C142724271 @default.
• W2088841888 hasConceptScore W2088841888C168563851 @default.
• W2088841888 hasConceptScore W2088841888C181199279 @default.
• W2088841888 hasConceptScore W2088841888C185592680 @default.
• W2088841888 hasConceptScore W2088841888C204787440 @default.
• W2088841888 hasConceptScore W2088841888C27081682 @default.
• W2088841888 hasConceptScore W2088841888C2778582115 @default.
• W2088841888 hasConceptScore W2088841888C2779689624 @default.
• W2088841888 hasConceptScore W2088841888C2779944601 @default.
• W2088841888 hasConceptScore W2088841888C42219234 @default.
• W2088841888 hasConceptScore W2088841888C55493867 @default.
• W2088841888 hasConceptScore W2088841888C71924100 @default.
• W2088841888 hasConceptScore W2088841888C90924648 @default.
• W2088841888 hasConceptScore W2088841888C98274493 @default.
• W2088841888 hasIssue "3" @default.
• W2088841888 hasLocation W20888418881 @default.
• W2088841888 hasLocation W20888418882 @default.
• W2088841888 hasOpenAccess W2088841888 @default.
• W2088841888 hasPrimaryLocation W20888418881 @default.

• next